Literature DB >> 11524395

Subvalvular gradients in patients with valvular aortic stenosis: prevalence, magnitude, and physiological importance.

W K Laskey1, W G Kussmaul.   

Abstract

BACKGROUND: Although subvalvular gradients in patients with aortic stenosis have been described, their behavior and response to exercise have not been well characterized. METHODS AND
RESULTS: Left ventricular and aortic pressures and linear flow velocity were measured with a catheter-tip manometer at rest and during supine exercise in 27 patients with valvular aortic stenosis. A subvalvular gradient was measured in each patient that represented, on average, 48% of the total resting transvalvular gradient. With exercise, both total (rest: 80+/-26 mm Hg; exercise: 90+/-25 mm Hg) and subvalvular gradients (rest: 37+/-13 mm Hg; exercise: 60+/-22 mm Hg) increased significantly. There was a significant inverse relationship between change in exercise cardiac output and total and subvalvular gradients. However, only the exercise subvalvular gradient predicted cardiac output response.
CONCLUSIONS: Subvalvular pressure gradients are universally present in patients with severe aortic stenosis and comprise approximately half of the total transvalvular gradient. The extent of exercise cardiac output increase is inversely related to the subvalvular gradient magnitude.

Entities:  

Mesh:

Year:  2001        PMID: 11524395     DOI: 10.1161/hc3401.095041

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  2 in total

Review 1.  Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.

Authors:  Ares Pasipoularides
Journal:  J Cardiovasc Transl Res       Date:  2016-02-18       Impact factor: 4.132

2.  A case report and analysis of hypertrophic obstructive cardiomyopathy causing an illusion of aortic stenosis.

Authors:  Ying Wang; Yue Ming Zhang; Jing Guang Dong; Li Jie Cheng; Guan Hua Jiang; Jian Wei Zheng; Wen Zhou Yu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.